Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma: A Case Report
Kaya Atagi, Shinkuro Yamamoto, Nobutaka Shimizu, Mitsuko Iguchi, Ryu Shigehisa, Tomoya Nao et al. Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma: A Case Report. // IJU Case Reports. – 2026. – DOI: 10.1002/iju5.70293. – URL: https://onlinelibrary.wiley.com/doi/10.1002/iju5.70293?af=R
Kaya Atagi, Shinkuro Yamamoto, Nobutaka Shimizu, Mitsuko Iguchi, Ryu Shigehisa, Tomoya Nao, Tsutomu Shimamoto, Hideo Fukuhara, Satoshi Fukata, & Keiji Inoue (2026). Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma: A Case Report. IJU Case Reports. https://doi.org/10.1002/iju5.70293
Kaya Atagi, et al. “Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma: A Case Report.” IJU Case Reports, 2026. doi:10.1002/iju5.70293.
@article{Atagi2026,
title = {Durable Complete Response to Pembrolizumab for Postoperative Nodal Recurrence of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma: A Case Report},
author = {Atagi, Kaya and Yamamoto, Shinkuro and Shimizu, Nobutaka and Iguchi, Mitsuko and Shigehisa, Ryu and Nao, Tomoya and Shimamoto, Tsutomu and Fukuhara, Hideo and Fukata, Satoshi and Inoue, Keiji},
journal = {IJU Case Reports},
year = {2026},
doi = {10.1002/iju5.70293},
url = {https://onlinelibrary.wiley.com/doi/10.1002/iju5.70293?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...